Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

NCI vs CLPS

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
NCI
Neo-Concept International Group Holdings Limited

Apparel - Manufacturers

Consumer CyclicalNASDAQ • HK
Market Cap$23M
5Y Perf.-82.5%
CLPS
CLPS Incorporation

Information Technology Services

TechnologyNASDAQ • HK
Market Cap$25M
5Y Perf.-5.6%

NCI vs CLPS — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
NCI logoNCI
CLPS logoCLPS
IndustryApparel - ManufacturersInformation Technology Services
Market Cap$23M$25M
Revenue (TTM)$236M$299M
Net Income (TTM)$8M$-4M
Gross Margin21.0%22.8%
Operating Margin4.9%-1.4%
Forward P/E21.7x
Total Debt$70M$34M
Cash & Equiv.$9M$28M

NCI vs CLPSLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

NCI
CLPS
StockApr 24May 26Return
Neo-Concept Interna… (NCI)10017.5-82.5%
CLPS Incorporation (CLPS)10094.4-5.6%

Price return only. Dividends and distributions are not included.

Quick Verdict: NCI vs CLPS

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: NCI and CLPS are tied at the top with 3 categories each — the right choice depends on your priorities. CLPS Incorporation is the stronger pick specifically for capital preservation and lower volatility and dividend income and shareholder returns. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
NCI
Neo-Concept International Group Holdings Limited
The Growth Play

NCI carries the broadest edge in this set and is the clearest fit for growth exposure and sleep-well-at-night.

  • Rev growth 35.3%, EPS growth 81.8%, 3Y rev CAGR -0.7%
  • Lower volatility, beta -1.05, current ratio 1.84x
  • Beta -1.05, current ratio 1.84x
Best for: growth exposure and sleep-well-at-night
CLPS
CLPS Incorporation
The Income Pick

CLPS is the clearest fit if your priority is income & stability and long-term compounding.

  • Dividend streak 3 yrs, beta 0.27, yield 14.6%
  • -78.5% 10Y total return vs NCI's -97.1%
  • Lower D/E ratio (58.8% vs 122.5%)
Best for: income & stability and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthNCI logoNCI35.3% revenue growth vs CLPS's 15.2%
Quality / MarginsNCI logoNCI3.4% margin vs CLPS's -1.3%
Stability / SafetyCLPS logoCLPSLower D/E ratio (58.8% vs 122.5%)
DividendsCLPS logoCLPS14.6% yield; 3-year raise streak; the other pay no meaningful dividend
Momentum (1Y)CLPS logoCLPS-5.4% vs NCI's -30.6%
Efficiency (ROA)NCI logoNCI7.1% ROA vs CLPS's -3.2%, ROIC 10.6% vs -7.9%

NCI vs CLPS — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

NCINeo-Concept International Group Holdings Limited
FY 2018
Health Care
57.8%$389M
Financial Services Advisory And Compliance
21.4%$144M
Energy
20.7%$140M
CLPSCLPS Incorporation
FY 2025
Other Member
100.0%$894,598

NCI vs CLPS — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLCLPSLAGGINGNCI

Income & Cash Flow (Last 12 Months)

Evenly matched — NCI and CLPS each lead in 2 of 4 comparable metrics.

CLPS and NCI operate at a comparable scale, with $299M and $236M in trailing revenue. Profitability is closely matched — net margins range from 3.4% (NCI) to -1.3% (CLPS).

MetricNCI logoNCINeo-Concept Inter…CLPS logoCLPSCLPS Incorporation
RevenueTrailing 12 months$236M$299M
EBITDAEarnings before interest/tax-$1M
Net IncomeAfter-tax profit-$4M
Free Cash FlowCash after capex$0
Gross MarginGross profit ÷ Revenue+21.0%+22.8%
Operating MarginEBIT ÷ Revenue+4.9%-1.4%
Net MarginNet income ÷ Revenue+3.4%-1.3%
FCF MarginFCF ÷ Revenue-8.0%-2.3%
Rev. Growth (YoY)Latest quarter vs prior year+15.3%
EPS Growth (YoY)Latest quarter vs prior year+75.8%
Evenly matched — NCI and CLPS each lead in 2 of 4 comparable metrics.

Valuation Metrics

CLPS leads this category, winning 3 of 3 comparable metrics.
MetricNCI logoNCINeo-Concept Inter…CLPS logoCLPSCLPS Incorporation
Market CapShares × price$23M$25M
Enterprise ValueMkt cap + debt − cash$30M$31M
Trailing P/EPrice ÷ TTM EPS21.73x-3.48x
Forward P/EPrice ÷ next-FY EPS est.
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple13.47x
Price / SalesMarket cap ÷ Revenue0.75x0.15x
Price / BookPrice ÷ Book value/share3.11x0.43x
Price / FCFMarket cap ÷ FCF
CLPS leads this category, winning 3 of 3 comparable metrics.

Profitability & Efficiency

NCI leads this category, winning 5 of 8 comparable metrics.

NCI delivers a 29.6% return on equity — every $100 of shareholder capital generates $30 in annual profit, vs $-6 for CLPS. CLPS carries lower financial leverage with a 0.59x debt-to-equity ratio, signaling a more conservative balance sheet compared to NCI's 1.22x. On the Piotroski fundamental quality scale (0–9), NCI scores 6/9 vs CLPS's 2/9, reflecting solid financial health.

MetricNCI logoNCINeo-Concept Inter…CLPS logoCLPSCLPS Incorporation
ROE (TTM)Return on equity+29.6%-6.1%
ROA (TTM)Return on assets+7.1%-3.2%
ROICReturn on invested capital+10.6%-7.9%
ROCEReturn on capital employed+19.8%-9.8%
Piotroski ScoreFundamental quality 0–962
Debt / EquityFinancial leverage1.22x0.59x
Net DebtTotal debt minus cash$60M$6M
Cash & Equiv.Liquid assets$9M$28M
Total DebtShort + long-term debt$70M$34M
Interest CoverageEBIT ÷ Interest expense3.08x
NCI leads this category, winning 5 of 8 comparable metrics.

Total Returns (Dividends Reinvested)

CLPS leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in CLPS five years ago would be worth $3,073 today (with dividends reinvested), compared to $234 for NCI. Over the past 12 months, CLPS leads with a -5.4% total return vs NCI's -30.6%. The 3-year compound annual growth rate (CAGR) favors CLPS at 0.2% vs NCI's -71.4% — a key indicator of consistent wealth creation.

MetricNCI logoNCINeo-Concept Inter…CLPS logoCLPSCLPS Incorporation
YTD ReturnYear-to-date-2.6%-10.3%
1-Year ReturnPast 12 months-30.6%-5.4%
3-Year ReturnCumulative with dividends-97.7%+0.5%
5-Year ReturnCumulative with dividends-97.7%-69.3%
10-Year ReturnCumulative with dividends-97.1%-78.5%
CAGR (3Y)Annualised 3-year return-71.4%+0.2%
CLPS leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

Evenly matched — NCI and CLPS each lead in 1 of 2 comparable metrics.

NCI is the less volatile stock with a -1.05 beta — it tends to amplify market swings less than CLPS's 0.27 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CLPS currently trades 48.2% from its 52-week high vs NCI's 8.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricNCI logoNCINeo-Concept Inter…CLPS logoCLPSCLPS Incorporation
Beta (5Y)Sensitivity to S&P 500-1.05x0.27x
52-Week HighHighest price in past year$13.81$1.88
52-Week LowLowest price in past year$0.32$0.80
% of 52W HighCurrent price vs 52-week peak+8.0%+48.2%
RSI (14)Momentum oscillator 0–10038.249.8
Avg Volume (50D)Average daily shares traded3.3M15K
Evenly matched — NCI and CLPS each lead in 1 of 2 comparable metrics.

Analyst Outlook

CLPS leads this category, winning 1 of 1 comparable metric.

CLPS is the only dividend payer here at 14.60% yield — a key consideration for income-focused portfolios.

MetricNCI logoNCINeo-Concept Inter…CLPS logoCLPSCLPS Incorporation
Analyst RatingConsensus buy/hold/sell
Price TargetConsensus 12-month target
# AnalystsCovering analysts
Dividend YieldAnnual dividend ÷ price+14.6%
Dividend StreakConsecutive years of raises13
Dividend / ShareAnnual DPS$0.13
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%
CLPS leads this category, winning 1 of 1 comparable metric.
Key Takeaway

CLPS leads in 3 of 6 categories (Valuation Metrics, Total Returns). NCI leads in 1 (Profitability & Efficiency). 2 tied.

Best OverallCLPS Incorporation (CLPS)Leads 3 of 6 categories
Loading custom metrics...

NCI vs CLPS: Frequently Asked Questions

8 questions · data-driven answers · updated daily

01

Is NCI or CLPS a better buy right now?

For growth investors, Neo-Concept International Group Holdings Limited (NCI) is the stronger pick with 35.

3% revenue growth year-over-year, versus 15. 2% for CLPS Incorporation (CLPS). Neo-Concept International Group Holdings Limited (NCI) offers the better valuation at 21. 7x trailing P/E, making it the more compelling value choice. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — NCI or CLPS?

Over the past 5 years, CLPS Incorporation (CLPS) delivered a total return of -69.

3%, compared to -97. 7% for Neo-Concept International Group Holdings Limited (NCI). Over 10 years, the gap is even starker: CLPS returned -78. 5% versus NCI's -97. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — NCI or CLPS?

By beta (market sensitivity over 5 years), Neo-Concept International Group Holdings Limited (NCI) is the lower-risk stock at -1.

05β versus CLPS Incorporation's 0. 27β — meaning CLPS is approximately -126% more volatile than NCI relative to the S&P 500. On balance sheet safety, CLPS Incorporation (CLPS) carries a lower debt/equity ratio of 59% versus 122% for Neo-Concept International Group Holdings Limited — giving it more financial flexibility in a downturn.

04

Which is growing faster — NCI or CLPS?

By revenue growth (latest reported year), Neo-Concept International Group Holdings Limited (NCI) is pulling ahead at 35.

3% versus 15. 2% for CLPS Incorporation (CLPS). On earnings-per-share growth, the picture is similar: Neo-Concept International Group Holdings Limited grew EPS 81. 8% year-over-year, compared to -181. 4% for CLPS Incorporation. Over a 3-year CAGR, CLPS leads at 2. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — NCI or CLPS?

Neo-Concept International Group Holdings Limited (NCI) is the more profitable company, earning 3.

4% net margin versus -4. 3% for CLPS Incorporation — meaning it keeps 3. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NCI leads at 4. 9% versus -4. 0% for CLPS. At the gross margin level — before operating expenses — NCI leads at 21. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Which pays a better dividend — NCI or CLPS?

In this comparison, CLPS (14.

6% yield) pays a dividend. NCI does not pay a meaningful dividend and should not be held primarily for income.

07

Is NCI or CLPS better for a retirement portfolio?

For long-horizon retirement investors, Neo-Concept International Group Holdings Limited (NCI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -1.

05)). Both have compounded well over 10 years (NCI: -97. 1%, CLPS: -78. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

08

What are the main differences between NCI and CLPS?

These companies operate in different sectors (NCI (Consumer Cyclical) and CLPS (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

CLPS pays a dividend while NCI does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

NCI

High-Growth Disruptor

  • Sector: Consumer Cyclical
  • Market Cap > $100B
  • Revenue Growth > 17%
  • Gross Margin > 12%
Run This Screen
Stocks Like

CLPS

High-Growth Disruptor

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 7%
  • Gross Margin > 13%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform NCI and CLPS on the metrics below

Revenue Growth>
%
(NCI: 35.3% · CLPS: 15.3%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.